Search Results

There are 20606 results for: content related to: The role of CD95/CD95 Ligand Signaling in Apoptosis and Cancer

  1. You have free access to this content
    CD95 ligand expression as a mechanism of immune escape in breast cancer

    Immunology

    Volume 99, Issue 1, January 2000, Pages: 69–77, M. Müschen, C. Moers, U. Warskulat, J. Even, D. Niederacher and M. W. Beckmann

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2567.2000.00921.x

  2. CD95 Ligand: Lethal Weapon Against Malignant Glioma?

    Brain Pathology

    Volume 8, Issue 2, April 1998, Pages: 285–293, Michael Weller, Paul Kleihues, Johannes Dichgans and Hiroko Ohgaki

    Version of Record online : 5 APR 2006, DOI: 10.1111/j.1750-3639.1998.tb00154.x

  3. You have free access to this content
    Hyperosmolarity triggers CD95 membrane trafficking and sensitizes rat hepatocytes toward CD95L-induced apoptosis

    Hepatology

    Volume 36, Issue 3, September 2002, Pages: 602–614, Roland Reinehr, Dirk Graf, Richard Fischer, Freimut Schliess and Dieter Häussinger

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2002.35447

  4. You have free access to this content
    Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells

    Hepatology

    Volume 27, Issue 1, January 1998, Pages: 200–208, Markus Müschen, Ulrich Warskulat, Patrice Douillard, Emmanuelle Gilbert and Dieter Häussinger

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510270131

  5. CD95 ligand expression in dedifferentiated breast cancer

    The Journal of Pathology

    Volume 189, Issue 3, November 1999, Pages: 378–386, Markus Müschen, Cordula Moers, Ulrich Warskulat, Dieter Niederacher, Beate Betz, Jos Even, Annick Lim, Régis Josien, Matthias W. Beckmann and Dieter Häussinger

    Version of Record online : 27 OCT 1999, DOI: 10.1002/(SICI)1096-9896(199911)189:3<378::AID-PATH439>3.0.CO;2-D

  6. You have free access to this content
    Evidence for multiple CD95–CD95 ligand interactions in anteriorchamber-associated immune deviation induced by soluble protein antigen

    Immunology

    Volume 99, Issue 3, March 2000, Pages: 451–457, T. Kezuka and J. W. Streilein

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2567.2000.00983.x

  7. You have free access to this content
    Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR

    FEBS Letters

    Volume 458, Issue 2, September 17, 1999, Pages: 209–214, Marcello Pinti, Jessica Pedrazzi, Francesca Benatti, Veronica Sorrentino, Cira Nuzzo, Valeria Cavazzuti, Priscilla Biswas, Daniela Nicoleta Petrusca, Cristina Mussini, Bruno De Rienzo and Andrea Cossarizza

    Version of Record online : 10 SEP 1999, DOI: 10.1016/S0014-5793(99)01131-X

  8. You have free access to this content
    Apoptosis signaling by death receptors

    European Journal of Biochemistry

    Volume 254, Issue 3, June (II) 1998, Pages: 439–459, Klaus Schulze-Osthoff, Davide Ferrari, Marek Los, Sebastian Wesselborg and Marcus E. Peter

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1998.2540439.x

  9. You have free access to this content
    T cell activation-induced and HIV Tat-enhanced CD95(APO-1 / Fas) ligand transcription involves NF-κB

    European Journal of Immunology

    Volume 30, Issue 2, February 2000, Pages: 661–670, Min Li-Weber, Oskar Laur, Kirsten Dern and Peter H. Krammer

    Version of Record online : 28 AUG 2000, DOI: 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO;2-L

  10. You have free access to this content
    Tumor counterattack – concept and reality

    European Journal of Immunology

    Volume 30, Issue 3, March 2000, Pages: 725–731, Frederik H. Igney, Christian K. Behrens and Peter H. Krammer

    Version of Record online : 28 AUG 2000, DOI: 10.1002/1521-4141(200003)30:3<725::AID-IMMU725>3.0.CO;2-D

  11. CD95 is cytoprotective for intestinal epithelial cells in colitis

    Inflammatory Bowel Diseases

    Volume 16, Issue 6, June 2010, Pages: 1063–1070, Sun-Mi Park, Lina Chen, Manling Zhang, Philip Ashton-Rickardt, Jerrold R. Turner and Marcus E. Peter

    Version of Record online : 4 JAN 2010, DOI: 10.1002/ibd.21195

  12. You have free access to this content
    Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells

    FEBS Letters

    Volume 429, Issue 1, June 05, 1998, Pages: 67–72, Markus Vogt, Manuel K.A Bauer, Davide Ferrari and Klaus Schulze-Osthoff

    Version of Record online : 25 JUN 1998, DOI: 10.1016/S0014-5793(98)00562-6

  13. You have full text access to this Open Access content
    Death receptors as targets for anti-cancer therapy

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 6b, December 2008, Pages: 2566–2585, Kerstin Papenfuss, Stefanie M. Cordier and Henning Walczak

    Version of Record online : 6 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00514.x

  14. You have free access to this content
    Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178) 1

    FEBS Letters

    Volume 519, Issue 1-3, May 22, 2002, Pages: 50–58, Markus Philipp Ghadimi, Ralf Sanzenbacher, Bernd Thiede, Jennifer Wenzel, Qian Jing, Markus Plomann, Arndt Borkhardt, Dieter Kabelitz and Ottmar Janssen

    Version of Record online : 23 APR 2002, DOI: 10.1016/S0014-5793(02)02709-6

  15. Cell density modulates apoptosis in human articular chondrocytes

    Journal of Cellular Physiology

    Volume 180, Issue 3, September 1999, Pages: 439–447, Klaus Kühn, Sanshiro Hashimoto and Martin Lotz

    Version of Record online : 14 JUL 1999, DOI: 10.1002/(SICI)1097-4652(199909)180:3<439::AID-JCP15>3.0.CO;2-D

  16. You have free access to this content
    Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor1

    FEBS Letters

    Volume 509, Issue 2, December 07, 2001, Pages: 255–262, Jennifer Wenzel, Ralf Sanzenbacher, Markus Ghadimi, Marc Lewitzky, Qingchun Zhou, David R. Kaplan, Dieter Kabelitz, Stephan M. Feller and Ottmar Janssen

    Version of Record online : 27 NOV 2001, DOI: 10.1016/S0014-5793(01)03174-X

  17. You have free access to this content
    Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: Characterization of an in Vitro system

    Hepatology

    Volume 32, Issue 4, October 2000, Pages: 779–785, Stephan F. Schlosser, Francesco Azzaroli, Tao Dao, Ravi Hingorani, I. Nicholas Crispe and James L. Boyer

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2000.18422

  18. You have free access to this content
    Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-co-stimulated human T cells

    European Journal of Immunology

    Volume 30, Issue 10, October 2000, Pages: 2765–2774, Sabine Kirchhoff, Wolfgang W. Müller, Min Li-Weber and Peter H. Krammer

    Version of Record online : 29 NOV 2000, DOI: 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W

  19. Expression of CD95 ligand in melanocytic lesions as a diagnostic marker

    British Journal of Dermatology

    Volume 139, Issue 2, August 1998, Pages: 198–206, Maeda, Aragane and Tezuka

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2133.1998.02355.x

  20. Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond

    Inflammatory Bowel Diseases

    Volume 16, Issue 6, June 2010, Pages: 1071–1076, Lina Chen, Sun-Mi Park, Jerrold R. Turner and Marcus E. Peter

    Version of Record online : 4 JAN 2010, DOI: 10.1002/ibd.21191